Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 1 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Aligos Therapeutics Inc have a median target of 75.00, with a high estimate of 175.00 and a low estimate of 60.00. The median estimate represents a 636.02% increase from the last price of 10.19.
High | 1,617.4% | 175.00 |
Med | 636.0% | 75.00 |
Low | 488.8% | 60.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 10, 2025.
Average growth rate | +23.17% |
Average growth rate | +46.69% |
More ▼
Revenue history & estimates in USD
Average growth rate | -15.42% |
Average growth rate | +93.09% |
More ▼